Regenerative Medical Technology (RMTG) EPS (Basic) Growth (3y) (2021 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn | 51.67% |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 39.50% |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn | 32.71% |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 44.39% |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn | 34.14% |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn | -53.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -53.86% |
| Mar 31, 2026 | -192.49% |
| Dec 31, 2025 | 2.15% |
| Sep 30, 2025 | -41.93% |
| Jun 30, 2025 | 5.28% |
| Mar 31, 2025 | 24.17% |
| Dec 31, 2024 | 27.88% |
| Sep 30, 2024 | 55.90% |
| Jun 30, 2024 | -37.75% |
| Mar 31, 2024 | -53.46% |
| Dec 31, 2023 | 22.51% |
| Sep 30, 2023 | -32.26% |
| Jun 30, 2023 | 23.90% |
| Mar 31, 2023 | 54.18% |
| Dec 31, 2022 | 11.91% |
| Sep 30, 2022 | -31.07% |
| Jun 30, 2022 | -45.16% |
| Mar 31, 2022 | -50.53% |
| Dec 31, 2021 | -41.27% |
| Sep 30, 2021 | -117.01% |